Delivery Order SPE2DB24D2205-SPE2DB25FEFMY
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Viscoat Syringes (0.5 mL), valued at $3,087.53. This firm fixed-price delivery order, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Viscoat syringes (0.75ML) under a firm fixed-price contract valued at $21,916.13. The order was competitively awarded without set-aside designation and is scheduled for completion by August 6, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,168.21 to AmerisourceBergen Drug Corp for the supply of Viscoat Syringes in 0.5 mL quantities. This firm fixed price, non-set-aside contract was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a delivery order, this award falls under a larger contract vehicle that enables AmerisourceBergen to supply pharmaceutical...
- The Defense Logistics Agency awarded a $8,825.82 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Viscoat Syringes in 0.5ml quantities. The delivery order, which closes on July 24, 2025, represents a competitively awarded contract with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under AmerisourceBergen's...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,352.41 Firm Fixed Price Delivery Order is for the supply of 0.75 milliliter Viscoat Syringes, with a period of performance through June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against their indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. Valued at $2,835.96, this order is for the supply of 0.75ml VISCOAT SYRINGES to support DLA medical facilities. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all supplies delivered by October 31, 2023. No set-aside designation was applied to this award. As a...
- Amerisourcebergen Drug Corp has received a $2,201.40 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply VISCOAT SYRINGE 0.5ML. As the prime contractor, Amerisourcebergen will deliver the specified pharmaceutical products from its Conshohocken, Pennsylvania headquarters by October 30, 2023. Amerisourcebergen is a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution services company. The delivery...
- The Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $3,565.34 firm-fixed-price contract is for the delivery of 0.75 mL VISCOAT syringes. This award is under a larger Indefinite Delivery Contract valued at up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of medical commodities to support military treatment programs...
- This federal contract award, valued at $3,928.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 0.5 mL Viscoat syringes. The contract is a Firm Fixed Price Delivery Order that does not utilize any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of a 0.5 mL VISCOAT syringe, with a ceiling value of $1,166.70. The contract is a Firm Fixed Price, Delivery Order with a period of performance through May 3, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFMYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,066.90 to AmerisourceBergen Drug Corp for the supply of Viscoat syringes in 0.5ML configuration. This competitive, non-set-aside contract operates under a firm fixed price structure with an ultimate completion date of July 30, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued as a child contract under AmerisourceBergen's broader DLA Troop Support Medical Indefinite Delivery Contract (IDC SPE2DX), a $1 billion prime vendor agreement valued through December 2026 that authorizes the company to supply comprehensive pharmaceutical and medical supply solutions to support military healthcare programs globally. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and broader military healthcare systems. The company's extensive federal contract portfolio demonstrates consistent capability to deliver medical products ranging from specialty medications to medical devices and supplies through competitive procurement processes. The Viscoat syringe delivery order represents a routine transactional fulfillment under the company's prime vendor authorization, contributing to the DLA's medical supply chain operations that support military and veteran healthcare requirements worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 7/29/25 |